Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
These medications might pose unique risks to people who are not overweight, including malnutrition, as well as muscle mass loss, side effects of the drug that can affect anyone but that could be especially concerning in people with lower starting B.M.I.s.
Simplified Text
GLP-1 medications may pose unique risks, such as malnutrition and muscle mass loss, for individuals who are not overweight, especially those with lower starting BMIs.
Confidence Score
1.000
Claim Maker
Dr. Nils Krüger
Context Type
News Article
Context Details
{
    "date": "2026-09-22",
    "person": "Dr. Nils Kr\u00fcger",
    "potential_risks": "malnutrition, muscle mass loss",
    "affected_population": "people who are not overweight, especially those with lower starting B.M.I.s"
}
Subject Tags
Malnutrition GLP-1 Drug Risks Side Effects Muscle Loss BMI
UUID
2ccaf3d6-d48a-4882-92d9-8d0d7eb57a1f
Vector Index
✗ No vector
Created
September 25, 2026 at 10:06 AM (2 weeks ago)
Last Updated
September 25, 2026 at 10:06 AM (2 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html
GLP-1 Prescriptions for People With No Medical Need Are Climbing
Completed News
7 claims
2 weeks ago
https://nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html

A new study analyzing over 92 million U.S. adult medical records found more than 1.1 million people taking GLP-1 medications without an apparent medical reason like obesity or diabetes. Doctors express concern over off-label use, potential risks, and the cultural phenomenon surrounding these drugs.

GLP-1 drugs Ozempic Off-label prescriptions Weight loss drugs Medical ethics Public health Obesity Diabetes

Similar Claims (5)

Other claims identified as semantically similar to this one.